freedrawpokergamesonline| LME metal warehouse receipt dynamics: copper, aluminum, nickel, zinc, lead and tin cancellations reduced by 54 to 3425 tons
News summary
The LME non-ferrous metal registered warehouse receipts report on May 24 showed that there were changes in the registration and cancellation of warehouse receipts for copper, aluminum, nickel and other metals.
Newsletter text
[London Metal Exchange reports: Copper inventories increase by 150 tons]
The latest non-ferrous metals inventory report from the London Metal Exchange (LME) was released on May 24. Report shows an increase in registered warehouse receipts for copperfreedrawpokergamesonline150 tons, reaching 99freedrawpokergamesonline, 125 tons, while cancelled warehouse receipts rose to 13,550 tons.
[Aluminum stocks decreased by 2,575 tons]
Registered warehouse receipts for aluminum remained at 653,400 tons, while cancelled warehouse receipts decreased by 2,575 tons to 471,300 tons, indicating a decline in market demand for aluminum.
[Nickel inventories fell slightly]
Registered warehouse receipts for nickel remained at 78,930 tons, while cancelled warehouse receipts decreased by 54 tons to 5,058 tons, indicating a slight decline in nickel stocks.
[Zinc inventories fall by 400 tons]
Registered warehouse receipts for zinc were 224,625 tons, and cancelled warehouse receipts decreased by 400 tons to 32,600 tons, indicating that zinc stocks have decreased.
[Lead stocks dropped significantly]
Registered warehouse receipts for lead were 151,650 tons, and cancelled warehouse receipts decreased significantly by 3,425 tons to 47,100 tons, indicating a significant decline in lead stocks.
[Tin stocks drop by 25 tons]
Registered warehouse receipts for tin were 4,855 tons, cancelled warehouse receipts decreased by 25 tons to 90 tons, and tin stocks decreased.
Tags:
Prev: crashbandicoot3nintendoswitch| Intuit(INTU.US)'s performance growth exceeded expectations, but outlook expectations were lowered: Q3 revenue of 6.74 billion yuan, earnings per share of $9.88
Next: playtoearnappscrypto| Shanghai Pharmaceutical (02607.HK): I040 received clinical trial approval notice